1. Rhim WI, Lew H, Yun YS. Clinical features of risk factors and regression of retinopathy of prematurity. J Korean Ophthalmol Soc. 2002; 43:1199–205.
2. Chung TY, Yu YS. Clinical outcome of spontaneously regressed ROP. J Korean Ophthalmol Soc. 2002; 43:1444–50.
3. Vander JF, McNamara JA, Tasman W, Brown GC. Revised indications for early treatment of retinopathy of prematurity. Arch Ophthalmol. 2005; 123:406–7.
Article
4. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003; 121:1684–94.
5. Palmer EA, Hardy RJ, Dobson V, et al. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol. 2005; 123:311–8.
6. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Pediatrics. 1988; 81:697–706.
7. Park EA, Kim GH. A clinical study for the time of development and risk factors of retinopathy of prematurity. Pediatrics. 1997; 40:945–54.
8. Kim TI, Sohn JH, Yoon YH, et al. Postnatal risk factors of retinopathy of prematurity. J Korean Ophthalmol Soc. 2000; 41:1229–35.
Article
9. Park JD, Kweon JH, Kim WH, et al. Incidence and risk factors of the retinopathy of prematurity. Pediatrics. 1996; 39:326–37.
10. Kim JH, Yu YS. Assessment of retinopathy of prematurity (ROP) revisited. Korean J Pediatr. 2009; 52:22–7.
Article
11. Yang MB, Donovan EF, Wagge JR. Race, gender, and clinical risk index for babies (CRIB) score as predictors of severe retinopathy of prematurity. J AAPOS. 2006; 10:253–61.
Article
12. Fortes Filho JB, Eckert GU, Valiatti FB, et al. The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP). Graefes Arch Clin Exp Ophthalmol. 2010; 248:893–900.
Article
13. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005; 123:991–9.
14. Yang MB, Donovan EF. Risk analysis and an alternative protocol for reduction of screening for retinopathy of prematurity. J AAPOS. 2009; 13:539–45.
Article
15. Rush R, Rush S, Nicolau J, et al. Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity. Retina. 2004; 24:242–5.
Article
16. Hellstrom A, Hard AL, Engstrom E, et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics. 2009; 123:638–45.
17. Hellstrom A, Ley D, Hansen-Pupp I, et al. New insights into the development of retinopathy of prematurity–importance of early weight gain. Acta Paediatr. 2010; 99:502–8.
18. Lofqvist C, Hansen-Pupp I, Andersson E, et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I. Arch Ophthalmol. 2009; 127:622–7.
Article
19. Wu C, Vanderveen DK, Hellstrom A, et al. Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2010; 128:443–7.
Article
20. Drenser KA, Trese MT, Capone A Jr. Aggressive posterior retinopathy of prematurity. Retina. 2010; 30(4 Suppl):S37–40.
Article